Looking for a Growth Stock? Why It is Time to Focus on Bio-Rad (BIO)
Growth stocks can be some of the most exciting
picks in the market, as these high-flyers can captivate investors’
attention, and produce big gains as well. However, they can also
lead on the downside when the growth story is over, so it is
important to find companies which are still seeing strong growth
prospects in their businesses.
One such company that might be well-positioned for future earnings
growth is Bio-Rad Laboratories, Inc. BIO. This
firm, which is in the Medical - Products, saw EPS growth of 42.4%
last year, and is looking great for this year too.
In fact, the current growth estimate for this year calls for
earnings-per-share growth of 22.6%. Furthermore, the long-term
growth rate is currently an impressive 15%, suggesting pretty good
prospects for the long haul.
Bio-Rad Laboratories, Inc. Price and Consensus
Bio-Rad Laboratories, Inc. Price and Consensus | Bio-Rad Laboratories, Inc. Quote
And if this wasn’t enough, the stock has actually
seen estimates rise over the past month for the current fiscal year
by about 5.6%. Thanks to this rise in earnings estimates, BIO has a
Zacks Rank #1 (Strong Buy) which further underscores the potential
for outperformance in this company. You can see the
complete list of today’s Zacks #1 Rank stocks here.
So, if you are looking for a fast-growing stock that is still
seeing plenty of opportunities on the horizon, make sure to
consider BIO. Not only does it have double-digit earnings growth
prospects, but its impressive Zacks Rank suggests that analysts
believe better days are ahead for BIO as well.
Is Your Investment Advisor Fumbling Your Financial
Future?
See how you can more effectively safeguard your retirement with a
new Special Report, “4 Warning Signs Your Investment Advisor Might
Be Sabotaging Your Financial Future.â€
Click to get it free >>
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free
report
Bio-Rad Laboratories, Inc.
(BIO) : Free Stock Analysis Report
To read this article on
Zacks.com click here.
Zacks Investment Research